SplitMay 14, 2026, 04:13 PM
Aspire Biopharma Announces 1-for-30 Reverse Stock Split
AI Summary
Aspire Biopharma Holdings, Inc. filed a Certificate of Amendment on May 11, 2026, to implement a 1-for-30 reverse stock split of its issued and outstanding common stock. As a result, every thirty existing shares will automatically convert into one new share, with fractional shares rounded up. The company's trading symbol will remain "ABSP," and a new CUSIP number, 738920305, has been assigned.
Key Highlights
- Aspire Biopharma filed a Certificate of Amendment to its Certificate of Incorporation on May 11, 2026.
- The amendment effects a 1-for-30 reverse stock split of the company's common stock.
- Every thirty shares of common stock will be combined into one share.
- Fractional shares resulting from the split will be rounded up to the nearest whole share.
- The company's trading symbol will remain "ABSP".
- A new CUSIP number, 738920305, has been assigned for the common stock.